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Metallothionein mice showed longer life span than FVB mice evaluated by the Kaplan-Meier survival curve
The Kaplan-Meier survival curve shows that metallothionein transgenic mice display a ϳ4 mo longer life span compared with FVB mice. The two curves start to separate from each other after 20 mo of age with metallothionein mice exhibiting a reduced mortality rate.
Aging-induced cardiac contractile defects were prevented by metallothionein
The mechanical and intracellular Ca 2ϩ defects triggered by advanced age have been well documented but limited research focuses on single cardiomyocytes. We assessed mechanical properties of ventricular myocytes using a SoftEdge MyoCam system. The aging-induced prolongation of time-to-90% relengthening (TR 90 ) was corrected by expression of the metallothionein transgene ( Fig. 1) . To explore the possible role of intracellular Ca 2ϩ homeostasis in aging and metallothioneinelicited response on cardiomyocyte mechanical function, we evaluated the intracellular Ca 2ϩ transients in fura-2-loaded myocytes. Consistent with prolonged TR 90 in myocytes from aged FVB mice, myocytes from these mice displayed a significantly reduced rate of intracellular Ca 2ϩ clearing, which was alleviated by metallothionein. Murine hearts contract at high frequencies. We examined the steady-state peak shortening amplitude under gradually increased stimulating frequency (0.1-5.0 Hz). The results demonstrate that peak shortening (PS) amplitude decreases dramatically with the increased stimulus frequency from 0.1 to 5.0 Hz. The degree of decline in peak shortening amplitude was significantly greater in the aged FVB group compared with young FVB mice, indicating decreased cardiac contractile reserve capacity at higher stress concentration under aging, while the aging-induced decline in peak shortening amplitude at high frequencies was blunted by expression of the metallothionein transgene.
Aging-induced changes in oxidative stress and related protein biomarkers in the hearts were attenuated by metallothionein
Enhanced oxidative stress is commonly found with advanced age. Measurement of superoxide production in cardiomyocytes by DHE fluorescence microscopy showed myocytes from aged FVB mice produced significantly higher levels of superoxide as compared with myocytes from young mice, and this effect was attenuated by metallothionein. To investigate the intrinsic cause-consequence link between aging-induced oxidative stress and metallothionein over-expression, we de-tected aconitase activity, NADPH oxidase concentration, active RhoA, cytochrome c release using several techniques such as fluorescence, Western blotting, ELISA, and determination of enzyme activity. NADPH oxidase is the most predominant source of superoxide generation, leading to a variety of cardiovascular diseases including diabetes, hypertension, and metabolic syndrome. Similar to its effect on superoxide generation, metallothionein alleviated aging-induced up-regulation of p47 phox , suggesting a potential antagonistic effect of metallothionein on NADPH oxidase (Fig. 2) . RhoA, a small GTPase, is well-documented as an inducer of oxidative stress. To explore the role of RhoA in aging-induced oxidative stress, active RhoA was determined by a pull-down assay. Not surprisingly, advanced age initiated an up-regulation of active RhoA, which was inhibited by expression of the metallothionein transgene. We also evaluated mitochondrial cytochrome c release as a marker for mitochondrial damage and found enhanced cytosolic cytochrome c levels in conjunction with reduced mitochondrial cytochrome c levels in aged FVB mouse hearts, indicating enhanced cytochrome c release. Nitrotyrosine is a biomarker for protein nitration by peroxynitrite. Evaluation of nitrotyrosine by ELISA indicated that neither aging nor metallothionein transgene expression affected nitrotyrosine formation, suggesting protein nitration is unlikely a major contributor to aging-induced cardiac defects. To further explore aging-induced oxidative stress, we measured cardiac aconitase levels. Aconitase is an iron-sulfur enzyme located in citric acid cycle, and the mitochondrial aconitase activity is closely associated with oxidative stress. Our results showed that aging led to decreased activity of aconitase, consistent with the previous studies, and metallothionein rectified the aging-induced decrease in aconitase activity. 
CONCLUSIONS AND SIGNIFICANCE
Recent data suggested that metallothionein, a low molecular wieght heavy metal chelating antioxidant, exerts protective effects against diabetes-and insulin resistance-induced cardiac damage. However, the impact of metallothionein on cardiac aging and life span has not been elucidated. Our present study revealed that metallothionein exerts similar effects against the aging process especially cardiac aging. Accumulation of oxygen free radicals or oxidative stress directly compromises ventricular function through NADPH oxidase activity, activation of stress signaling molecules, stimulation of renin-angiotensin system, and direct myogenic effects on heart muscles. Reduction of oxidative stress by either enzymatic or nonenzymatic antioxidants has been shown to improve cardiac function and reduce cardiac apoptosis. In the current study, advanced age elicited oxidative stress without hyperglycemia or hypertension, thus excluding contribution of diabetes and hypertension to our aging model. Data from this study revealed that ventricular myocytes from aged FVB mice displayed prolonged relaxation (TR 90 ), while all other mechanical indices (PS, maximal velocity of shortening/relengthening, time-to-peak shortening) were normal. Moreover, aged cardiomyocytes exhibited diminished stress tolerance manifested as significantly reduced peak shortening at higher stimulating frequencies. These data are consistent with our previous findings using murine model (at similar ages). Reduced intracellular Ca 2ϩ clearance rate in aged FVB myocytes is in line with prolonged relaxation duration and reduced intracellular Ca 2ϩ cycling ability (reduced PS at high stimulating frequencies) in cardiomyocytes from aged animals.
Given the facts that accumulation of oxygen free radicals or oxidative stress directly compromises ventricular function through NADPH oxidase activity, activation of stress signaling molecules, stimulation of renin-angiotensin system, and direct myogenic effects, our data suggest that metallothionein-elicited antagonism of aging-associated increase in oxidative stress may play a beneficial role against cardiac aging and prolong life span. Mitochondria have been speculated as the major site for oxidative stress-induced damage, although mammalian evidence is sparse. In present study, the aging-induced decrease of mitochondrial aconitase activity was alleviated by metallothionein showed us the possible role of metallothionein transgene. Recent evidence indicates that the small GTPase RhoA participates in the regulation of multiple cell functions, including adhesion, proliferation, migration, and Ca 2ϩ homeostasis through kinase cascade activation. The current results indicated that aging-induce active RhoA increase was corrected by metallothionein.
Collectively, our present data revealed that overexpression of the metallothionein transgene prolonged life span (Fig. 3) . Furthermore, the metallothionein transgene preserved cardiac contractile functions, improved intracellular Ca 2ϩ homeostasis, and restored cardiac contractile capacity under high stimulus frequency, which are cardiac dysfunctions in aged mice. All these function alterations are associated with oxidative stress biomarkers. These results disclose that metallothionein may be beneficial in protecting against aging-induced cardiac dysfunction and oxidative stress and, thus, may prolong life span. The prevalence of heart failure is significantly higher in the elderly compared with the middle-aged or young population, indicating that aging or senescence per se plays an important role in cardiac dysfunction (1) . Ample evidence has implicated free radical accumulation or oxidative stress as an essential culprit player in aging-related cardiovascular dysfunction (2-6). The "free radical theory of aging," first postulated by Harman (7), has been perhaps the most widely accepted hypothesis for the biology of aging. According to this theory, the progressively accumulated oxidant insult with increased age is responsible for enhanced oxidative stress en route to ultimate biological events of senescence (7) . The free radical theory of aging has paved its way to the modern concept of "mitochondrial theory of aging," which credits mitochondria as the main culprits for oxidative stress (8) . Aging-related accumulation of free radicals or oxidative stress has been demonstrated to be responsible for senescent organ damage including hearts (9 -11) . However, the precise mechanisms of action underlying aging-induced cardiac contractile dysfunction remain poorly understood. Recent data suggested that metallothionein, a low molecular weight heavy metal chelating antioxidant, exerts protective effects against diabetesand insulin resistance-induced cardiac damage (12) (13) (14) . However, the impact of metallothionein on cardiac aging and life span has not been elucidated. The aim of this investigation was to examine the effect of cardiacspecific over-expression of metallothionein on life span, cardiac aging, and oxidative stress. Our results revealed that expression of the metallothionein transgene prolonged life span, preserved cardiac contractile functions, improved intracellular Ca 2ϩ homeostasis, restored cardiac contractile capacity under high stimulus frequency in advanced age, and alleviated agingassociated elevation in biomarkers of oxidative stress and cell death. These data suggest that metallothion-ein-elicited antagonism of aging-associated increase in oxidative stress may play a beneficial role against cardiac aging and prolong life span.
MATERIALS AND METHODS

Experimental animals and Kaplan-Meier's survival curve
The experimental procedure was approved by the Institutional Animal Use and Care Committee at the University of Wyoming (Laramie, WY). All animal procedures were in accordance with the National Institute of Health animal care standards. Production and characterization of metallothionein transgenic mice were described in detail previously (14) . In brief, a 11.4 kb metallothionein cDNA construct driven by ␣-myosin heavy chain (␣-MHC) promoter containing entire coding sequences of the human metallothionein-IIa gene was purified on a matrix of diatemaceous earth (Prepagene; Bio-Rad Laboratories, Richmond, CA) and filtered through a 0.22 m filter. Approximately 100 copies of the purified transgene insert were microinjected into one pronucleus of each one-cell mouse embryo of the inbred strain FVB. Twenty microinjected embryos were implanted into each pseudopregnant female, which was allowed to come to term. For identification of the transgenic founder mice, genomic DNA isolated from 4-wk-old mice (by tail clips) was subjected to Southern and dot blot analyses was probed with an 850-bp NcoI/BglII fragment derived from the human metallothionein-IIa gene. This probe was hybridized with an 11.5-bp SacI fragment of the genomic DNA digests, consistent with the presence of a unique SacI site in the MHC-driven metallothionein-IIa transgene. Founder mice were cross-bred, and offspring were identified by PCR using a primer pair derived from the MHC promoter and human metallothionein-IIa gene. Male positive transgenic mice (heterozygotes with a 5-to 10-fold increase in metallothionein expression) and negative littermates were used for our current study at either 5-6 mo of age (denoted as "young") or 26 -28 mo of age (denotes as "aged"). Mice were maintained with a 12/12-light/dark cycle with free access to tap water. The fur color was used as a marker for metallothionein (dark brown) or WT FVB (white) mouse identification (13) . To configure the KaplanMeier survival curve, male FVB and metallothionein mice were separated after weaning (Ͻ12 mice per cage). Mice were checked weekly, and mortality was recorded every 2 months.
Cell isolation procedures
Mouse hearts were removed under anesthesia (150 mg/kg ketamine and 22.5 mg/kg xylazine, ip) and were perfused with Krebs-Henseleit bicarbonate buffer containing (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , 10 HEPES, 11.1 glucose (Glc), and 10 butanedione with 5% CO 2 -95% O 2 . Hearts were subsequently digested with 223 U/ml collagenase D (Boehringer Mannheim, Indianapolis, IN) for 10 min at 37°C. After perfusion, left ventricles were removed and minced. Extracellular Ca 2ϩ was incrementally added back to 1.25 mM. Cell viability was ϳ70% in all four animal groups. Functional studies were conducted between 1 and 8 h of isolation and myocytes with obvious sarcolemmal blebs or spontaneous contractions were not used for study (15) . To evaluate the involvement of RhoA in aging-associated alteration in mechanical function, a cohort of myocytes from young and aged FVB mice was incubated with the Rho kinase inhibitor Y-27632 (10 M) for 4 h in a defined medium consisting of Medium 199 with Earle's salts containing HEPES (25 mM) and NaHCO 3 (25 mM), supplemented with albumin (2 mg/ml), l-carnitine (2 mM), creatine (5 mM), taurine (5 mM), insulin (100 nM), penicillin (100 U/ml), streptomycin (100 g/ml), and gentamicin (5 g/ml) at 37°C.
Cell shortening/relengthening
Mechanical properties of ventricular myocytes were assessed using a SoftEdge MyoCam system (IonOptix Corporation, Milton, MA) (15) . In brief, left ventricular myocytes were placed in a chamber mounted on the stage of an inverted microscope (Olympus, IX-70) and superfused at 25°C with a buffer containing (in mM): 131 NaCl, 4 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 Glc, and 10 HEPES, at pH 7.4. The cells were field stimulated with suprathreshold voltage at a frequency of 0.5 Hz (unless otherwise stated), 3 msec duration, using a pair of platinum wires placed on opposite sides of the chamber connected to a FHC stimulator (Brunswick, NE). The myocyte being studied was displayed on a computer monitor using an IonOptix MyoCam camera. An IonOptix SoftEdge software was used to capture changes in cell length during shortening and relengthening. Cell shortening and relengthening were assessed using the following indices: peak shortening (PS), the amplitude myocytes shortened on electrical stimulation, an indicative of peak ventricular contractility; time-to-PS (TPS), the duration of myocyte shortening, an indicative of systolic duration; time-to-90% relengthening (TR 90 ), the duration to reach 90% relengthening, an indicative of diastolic duration (90% rather 100% relengthening was used to avoid noisy signal at baseline concentration); and maximal velocities of shortening/relengthening, maximal slope (derivative) of shortening and relengthening phases, indicative of maximal velocities of ventricular pressure increase/decrease. In the case of altering stimulus frequency, the steady-state contraction of myocyte was achieved (usually after the first 5-6 beats) before PS amplitude was recorded (1).
Intracellular Ca 2؉ transient measurement
Intracellular Ca 2ϩ was measured using a dual-excitation, single-emission photomultiplier system (IonOptix) in myocytes loaded with fura-2-acetoxymethyl ester (0.5 M) (15). Myocytes were placed on an inverted microscope and imaged through an Olympus (model: IX-70) Fluor ϫ 40 oil objective. Myocytes were exposed to light emitted by a 75-W halogen lamp through either a 360-or 380-nm filter while being stimulated to contract at 0.5 Hz. Fluorescence emissions were detected between 480 and 520 nm by a photomultiplier tube after initial illumination at 360 nm for 0.5 s and then at 380 nm for the duration of the recording protocol. The 360-nm excitation reading was repeated at the end of the protocol. Qualitative evaluation of intracellular Ca 2ϩ was inferred from fura-2 fluorescence intensity (FFI) changes (⌬FFI). A Chebyshev equation was used to evaluate the intracellular Ca 2ϩ decay constant. Myocyte shortening was also evaluated in a cohort of the fura-2-loaded ventricular myocytes simultaneously to compare their temporal relationship with the fluorescence signal. However, their mechanical properties were not used for data summary due to the apparent Ca 2ϩ buffering effect of fura-2.
Intracellular fluorescence measurement of superoxide
Intracellular superoxide concentration was monitored by changes in fluorescence intensity resulting from intracellular probe oxidation, as described previously (16) . Freshly isolated cardiac myocytes were loaded with 2.5 M dihydroethidium (DHE, Molecular Probes, Eugene, OR) for 15 min at 37°C, washed with PBS buffer, and loaded into coverslips. Cells were sampled randomly using an Olympus BX-51 microscope equipped with a MagnaFir SP digital camera and ImagePro image analysis software (Media Cybernetics, Silver Spring, MD). All test conditions were kept identical. The grid crossing method was employed for cell selection in more than 15 visual fields per cell group. To evaluate the effect of metallothionein on resistance to superoxide generation, cardiomyocytes from aged FVB and metallothionein mice were incubated with pyrogallol (100 M), a superoxide generator (17) , for 2 h before superoxide generation was determined.
Mitochondrial cytochrome c release
Ventricles were minced and homogenized by Polytron in ice-cold MSE buffer [220 mM mannitol, 70 mM sucrose, 2 mM ethylene glycol-bis(aminoethylether)-tetraacetic acid (EGTA), 5 mM 3-(4-morpholino) propane sulfonic acid (MOPS), pH 7.4, 0.2% BSA and a protease inhibitor cocktail containing 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF), E-64, bestatin, leupeptin, aprotinin, and sodium ethylenediaminetetraacetic acid (EDTA) (Sigma, St. Louis, MO)]. The homogenates were centrifuged for 10 min at 600 g to remove unbroken tissue and nuclei, and the supernatants were centrifuged for 10 min at 3000 g to pellet mitochondria. The supernatants were further centrifuged for 1 h at 16,000 g at 4°C to obtain cytosol. The mitochondrial pellet was dissolved in radio-immuno-precipitation assay (RIPA) lysis buffer containing 150 mM NaCl, 0.25 deoxycholic acid, 1% Nonidet P-40, 1 mM EDTA, 50 mM Tris-HCl, pH 7.4 (Upstate, Lake Placid, NY), and 1% protease inhibitor cocktail and centrifuged at 10,000 g for 30 min at 4°C to make a soluble protein. Supernatants were collected and protein concentrations were determined by Micro bicinchoninic acid (BCA) protein assay kit (Pierce Chemical, Rockford, IL). Proteins were boiled in Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA); 50 g protein of mitochondrial fraction or cytosol were separated by 15% sodium dodecyl sulfate PAGE (SDS-PAGE) in a Mini-PROTEAN II minigel apparatus (BioRad Laboratories, Hercules, CA) and electrophoretically transferred to a nitrocellulose membrane. The membranes were incubated for 1 h at room temperature in blocking buffer (5% w/v non fat dry milk in tris buffered saline containing 0.1% Tween 20, TBS-T). Membranes were incubated in anti-rabbit cytochrome c polyclonal antibody (pAb) 1:1000 followed by incubation with horseradish peroxidasecoupled anti-rabbit secondary antibody (Ab; Cell Signaling Technology, Beverly, MA). Immunoreactive bands were visualized using enhanced chemiluminescence reagents (Cell Signaling Technology). After immunoblotting, the film was scanned and the intensity of immunoblot bands was detected with a GS-800 Calibrated Densitometer (Bio-Rad Laboratories, Hercules, CA). Blots for cytosol were stripped and reprobed with Ab directed monoclonal antimouse ␤-actin, which serves as an internal loading control (Cell Signaling Technology) (18) .
Nitrotyrosine determination
Myocardial tissue was homogenized in RIPA lysis buffer with 1% protease inhibitor cocktail using a PRO 200 homogenizer followed by sonication with a dismembrator (Fisher Scientific, Pittsburgh, PA). Homogenates were centrifuged for 10 min at 12,500 g at 4°C. Supernatants were collected, and lysates containing 100 g protein were applied to disposable sterile microtiter plates (Corning Glassworks, Corning, NY) and incubated overnight at 4°C. The plate was then washed twice with 200 l of TBS-T followed by incubation with heatinactivated 200 l 1% BSA in TBS for 1 h at 37°C to block nonspecific binding. After being washed three times with TBS-T, rabbit pAb against nitrotyrosine (Cell Signaling Technology; 1:2000 dilution) was added to incubate for 1 h at 37°C followed by addition of secondary Ab (horseradish peroxi- Western blot analysis of metallothionein and NADPH oxidase subunit was performed on total protein lysate prepared from procedure as described above. Briefly, protein samples were separated on 10% SDS-polyacrylamide gels in a minigel apparatus and transferred to nitrocellulose membranes. Membranes were probed with antimouse metallothionein, antimouse p47 phox , and anti-␤-actin antibodies (19, 20) followed by incubation with horseradish peroxidase-coupled antimouse secondary Ab (Cell Signaling Technology). Metallothionein Ab was purchased from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Santa Cruz, CA). After immunoblotting, the film was scanned and intensity of immunoblot bands was detected with a Bio-Rad calibrated densitometer (21) . ␤-actin was used as an internal loading control. The monoclonal ␤-actin Ab was obtained from Cell Signaling Technology.
Aconitase activity
Mitochondrial fractions prepared from whole heart homogenate were resuspended in 0.2 mM sodium citrate. After determination of protein concentration using the bicinchoninic acid (BCA) protein assay kit and BSA as a standard, aconitase activity assay (Aconitase activity assay kit, Aconitase-340 assay, OxisResearch, Portland, OR) was performed according to manufacturer instructions with minor modifications. Briefly, mitochondrial sample (50 l) was mixed in a 96-well plate with 50 l trisodium citrate (substrate) in Tri-HCl pH 7.4, 50 l isocitrate dehydrogenase (enzyme) in Tris-HCl, and 50 l NADP in Tris-HCl. After being incubated for 15 min at 37°C with 50 rpm shaking (I2400 Incubator Shaker, New Brunswick Scientific, Edison, NJ), the absorbance was dynamically recorded at 340 nm every minute for 5 min with a SpectraMax 190 Microplate Spectrophotometer. During the assay, citrate is isomerized by aconitase into isocitrate and eventually ␣-ketoglutarate. The Aconitase-340 assay measures NADPH formation, a product of the oxidation of isocitrate to ␣-ketoglutarate. Tris-HCl buffer (pH 7.4) was served as blank (22) .
Determination of active RhoA
RhoA expression was measured according to the EZ-Detect Rho activity kit instructions (Pierce Chemical, Rockford, IL). Briefly, heart lysates known concentrations were pull-down in spin cup by adding of SwellGel Immobilized Gluthione Disc and glutathione S-transferase-Rhotekin-RBD. After incubation for 1 h at 4°C, the resin containing active Rho was carefully washed three times with wash buffer (provided by the supplier). The protein was recovered from resin by denaturing the resin. Regular Western blot was run as described as above, using 12% SDS-PAGE as separate gel. The nitrocellulose membrane was blocked in 3% BSA at room temperature for 2 h and incubated with 1:500 diluted antiRho primary Ab, followed by HRP-conjugated goat antimouse IgG secondary Ab (23) . For the total RhoA, conventional Western blot was directly performed with heart lysates to detect total RhoA concentration. Equal loading was confirmed by both protein concentration assay and ␤-actin.
Determination of apoptosis
To assess the effect of metallothionein on aging-induced apoptosis, cardiomyocytes from aged FVB and metallothionein mice were incubated with pyrogallol (100 M), a superoxide donor and a reactive oxygen species (ROS) inducer (17) , for 2 h before levels of cleaved caspase-9 was determined using Western blot analysis. Cleaved caspase-3 is a key biomarker of apoptosis (24) . After pyrogallol treatment, the cardiomyocytes were collected by centrifugation at 300 rpm for 5 min. The cells were lysed and Western blot was performed as described (19) . The membrane was probed with caspase-9 Ab (Cell Signaling Technology, 1:1000 dilution).
Statistical analyses
Data are presented as mean Ϯ se. Log rank test was used for Kaplan-Meier survival curve (25) . Statistical significance (PϽ0.05) for all other variables was determined by ANOVA followed by a Dunnett's post hoc analysis.
RESULTS
General features of young and aged FVB or metallothionein mice
There were no differences in body, heart, liver, and kidney weights as well as organ size (normalized to body wt) between age-matched FVB and metallothionein over-expressing mice. The body and organ weights were significantly heavier in aged mice compared with younger ones, as expected. However, organ size of heart, liver, and kidney were similar between young and aged mice ( Table 1) . There was no difference in fasting Glc or blood pressure levels among the four mouse groups, excluding the presence of diabetes or hypertension (data not shown). Western blot analysis revealed that cardiac expression of metallothionein in young metallothionein transgenic mice was ϳ5-fold higher than that of young FVB mice. While aging itself did not affect metallothionein expression in FVB mice, the metallothionein expression in aged metallothionein mice was enhanced even further (ϳ7-fold higher than aged FVB; Fig. 1A) . The Kaplan-Meier survival curve shows that metallothionein transgenic mice display a ϳ4 mo longer life span compared with FVB mice (Fig. 1B) . The average life span was 30.14 Ϯ 1.76 and 26.49 Ϯ 1.75 mo in metallothionein and FVB groups, respectively (PϽ0.05 between the two groups using the log rank test). The two curves start to separate from each other after 20 mo of age with metallothionein mice exhibiting a reduced mortality rate.
Baseline mechanical and intracellular Ca 2؉ properties of left ventricular myocytes
Data shown in Fig. 2 indicate that time-to-90% relengthening (TR 90 ) was significantly prolonged in the aged FVB mouse group, while all other mechanical indices remain unchanged compared with young FVB group. Such aging-triggered diastolic dysfunction is consistent with our previous report (1) . Interestingly, the aginginduced prolongation of TR 90 was corrected by expression of the metallothionein transgene. To explore the possible role of intracellular Ca 2ϩ homeostasis in aging and metallothionein-elicited response on cardiomyocyte mechanical function, we evaluated the intracellular Ca 2ϩ transients in fura-2 loaded myocytes. Our result indicated similar resting FFI and ⌬FFI in myocytes from young and aged FVB groups. Consistent with prolonged TR 90 in myocytes from aged FVB mice, myocytes from these mice displayed a significantly reduced rate of intracellular Ca 2ϩ clearing, which was alleviated by metallothionein (Fig. 3) . Lastly, metallothionein expression itself did not affect the mechanical or intracellular Ca 2ϩ properties in young mice, indicating that the antioxidant does not innately influence intrinsic cardiomyocyte contractile function.
Effect of increasing stimulation frequency on myocyte shortening
Murine hearts contract at high frequencies. We examined the steady-state PS amplitude under gradually increased stimulating frequency (0.1-5.0 Hz). All recordings were normalized to PS obtained at 0.1 Hz for the same cardiomyocyte. The results demonstrate that PS amplitude decreases dramatically with increased stimulus frequency from 0.1 Hz to 5.0 Hz (Fig. 4A) . The degree of decline in PS amplitude was significantly greater in the aged FVB group compared with young FVB mice, indicating decreased cardiac contractile reserve capacity at higher stress concentration under aging, as reported previously (1). Interestingly, the aging-induced decline in peak shortening amplitude at high frequencies was blunted by expression of the metallothionein transgene. Metallothionein itself did not elicit any significant effect on stimulus frequency-PS relationship in myocytes from young mice. Lastly, changes in the stimulus frequency from 0.1 Hz to 5.0 Hz did not significantly affect the diastolic resting cell length (Fig. 4B) 
Intracellular superoxide levels and NADPH oxidase expression
Measurement of superoxide production in cardiomyocytes by DHE fluorescence microscopy (12, 16, 26) showed myocytes from aged FVB mice produced significantly higher levels of superoxide as compared with myocytes from young mice, and this effect was significantly attenuated by metallothionein (Fig. 5) . NADPH oxidase is the most predominant source of superoxide generation, leading to a variety of cardiovascular diseases including diabetes, hypertension and metabolic syndrome (1, 27) . Our data revealed significantly upregulated p47 phox subunit of the NADPH oxidase in aged FVB hearts compared with the young FVB group (Fig. 6) , consistent with elevated superoxide levels in the same mice. Similar to its effect on superoxide generation, metallothionein alleviated aging-induced up-regulation of p47 phox , suggesting a potential antagonistic effect of metallothionein on NADPH oxidase. These results suggest that NADPH oxidase is likely responsible for aging-induced elevation in superoxide levels and further confirmed the notion of metallothionein as a free radical scavenger (12-14, 28, 29) .
Effect of metallothionein on aging-induced increases of RhoA and cytochrome c release
Enhanced oxidative stress is often found in advanced age en route to irreversible damage of proteins or lipids (22) . However, proteins responsible for enhanced oxidative stress have not been carefully identified. RhoA, a small GTPase, is well-documented as an inducer of oxidative stress (30 -33) . To explore the role of RhoA in aging-induced oxidative stress, active RhoA was determined by a pull-down assay. Not surprisingly, advanced age initiated an up-regulation of active RhoA, which was inhibited by expression of the metallothionein transgene, but there is not a significant difference in total RhoA expression among the four animal groups examined (Fig. 7) . We also evaluated mitochondrial cytochrome c release as a marker for mitochondrial damage (12, 18) and found enhanced cytosolic cytochrome c levels in conjunction with reduced mitochondrial cytochrome c levels in aged FVB mouse hearts, indicating enhanced cytochrome c release (Fig.  8) . Similar to its effect on RhoA, metallothionein ablated aging-induced enhanced release of cytochrome c (Fig. 8) .
Nitrotyrosine formation and aconitase activity in FVB and metallothionein mice
Nitrotyrosine is a biomarker for protein nitration by peroxynitrite (12, 18, 34) . Evaluation of nitrotyrosine by ELISA indicated that neither aging nor metallothionein transgene expression affected nitrotyrosine formation, suggesting protein nitration is unlikely a major contributor to aging-induced cardiac defects (Fig. 9) . To further explore aging-induced oxidative stress, we measured cardiac aconitase levels. Aconitase is an ironsulfur enzyme located in citric acid cycle, and the mitochondrial aconitase activity is closely associated with oxidative stress (22, 35, 36) . For example, mitochondrial aconitase is readily damaged by oxidative Representative immunoblots of metallothionein and ␤-actin using specific antibodies. Mean Ϯ se; n ϭ 3; *P Ͻ 0.05 vs. FVB-Y group, # P Ͻ 0.05 vs. all other groups. B) Cumulative survival curves (Kaplan-Meier survival analysis) of male FVB and MT mice. Death of mice was checked weekly and reported every 4 months in the first 32 months and then every 2 months. Cumulative survival rate was plotted against the time course (nϭ55-56 mice/group). Life span was 26.49 Ϯ 1.75 vs. 30.14 Ϯ 1.76 monaths in FVB and MT mice, respectively. Mean Ϯ se; P Ͻ 0.05 between 2 groups evaluated by log rank test.
stress via removal of an iron from [4Fe-4S] cluster (37).
Our results showed that aging led to decreased activity of aconitase, consistent with the previous studies (22, 36) . Interestingly, metallothionein rectified the aginginduced decrease in aconitase activity (Fig. 9 ).
Sensitivity to pyrogallol-elicited apoptosis and superoxide generation in aged FVB and metallothionein mouse myocytes
To determine the effect of metallothionein on sensitivity of cardiomyocytes to ROS-induced apoptosis and superoxide generation, the superoxide generator pyrogallol (100 M) was used to induce superoxide generation and apoptosis (17) . Data displayed in Fig. 10 indicated that levels of cleaved caspase-9, an important indicator for apoptosis (24) and superoxide, were both significantly lower in aged metallothionein myocytes compared with aged FVB myocytes. These observations were consistent with reduced levels of p47 phox (Fig. 6 ), active RhoA (Fig. 7) , and cytosolic cytochrome c (Fig.  8) as well as higher aconitase activity (Fig. 9 ) in aged metallothionein group compared with aged FVB group. More interestingly, pyrogallol-induced signifi- cant increase in apoptosis and superoxide generation in aged FVB myocytes was either blunted (caspase-9) or significantly attenuated (superoxide generation) in aged metallothionein group, indicating overt resistance to pyrogallol-triggered myocyte superoxide generation and apoptosis by the metallothionein transgene.
Effect of Rho kinase inhibitor Y-27632 on cell shortening in young and aged FVB myocytes
To examine the role of RhoA and Rho kinase signaling in aging-associated cardiomyocyte contractile dysfunction, young and old FVB murine cardiomyocytes were incubated with the Rho kinase inhibitor Y-27632 (10 M) for 4 h before mechanical function was evaluated (38) . As shown in Fig. 11 , Y-27632 did not affect resting cell length in young or aged FVB groups. PS, Ϯ dL/dt, and TPS were not affected by either aging or Y-27632. Interestingly, aging-induced prolongation in TR 90 was blunted by coincubation of Y-27632. Y-27632 itself did not affect any cell mechanics in young FVB myocytes.
DISCUSSION
The major findings of our study are that aging elicits cardiac contractile and intracellular Ca 2ϩ dysfunction. Furthermore, aging-induced cardiac contractile and intracellular Ca 2ϩ dysfunction was causally associated with enhanced superoxide generation, p47 phox expression, RhoA activity, and mitochondrial cytochrome c release. Interestingly, these aging-associated alterations in contractile function (at both low and high stimulating frequencies) and oxidative stress signaling were significantly attenuated or abolished by cardiac overexpression of metallothionein. Consistent with the enhanced RhoA activity in aged cardiomyocytes, the aging-induced cardiomyocyte dysfunction was ablated by the Rho kinase inhibitor Y-27632. Metallothionein transgenic mice show a significant resistance to pyrogallol-elicited superoxide generation and apoptosis. Importantly, attenuation of these age-related effects was associated with prolonged life span in metallothionein transgenic mice. Although aging itself does not cause any reduction in cardiac metallothionein levels, our results indicate that metallothionein may be beneficial in protecting against aging-induced cardiac dysfunction, and oxidative stress and, thus, may prolong life span. Enhanced oxidative stress is commonly found with advanced age (10) . It was recently shown that overexpression of the antioxidant catalase, an enzyme known to reduce accumulation of ROS and subsequent oxidative stress, extends murine life span (36) . Mitochondria have been speculated as the major site for oxidative stress-induced damage, although mammalian evidence is sparse (39). Our present study revealed that metallothionein, another known free radical scavenger, exerts similar effects against the aging process especially cardiac aging. Accumulation of oxygen free radicals or oxidative stress directly compromises ventricu- lar function through NADPH oxidase activity, activation of stress signaling molecules, stimulation of renin-angiotensin system, and direct myogenic effects on heart muscles (40 -42) . Reduction of oxidative stress by either enzymatic or nonenzymatic antioxidants has been shown to improve cardiac function and reduce cardiac apoptosis (9, 43, 44 ). In the current study, advanced age elicited oxidative stress without hyperglycemia or hypertension, thus excluding contribution of diabetes and hypertension to our aging model. Data from our study revealed that ventricular myocytes from aged FVB mice displayed prolonged relaxation (TR 90 ), while all other mechanical indices (PS, maximal velocity of shortening/relengthening, time-to-PS) were normal. Moreover, aged cardiomyocytes exhibited diminished stress tolerance manifested as significantly reduced PS at higher stimulating frequencies. These data are consistent with our previous findings using murine model (at similar ages) (1). Reduced intracellular Ca 2ϩ clearance rate in aged FVB myocytes is in line with prolonged relaxation duration and reduced intracellular Ca 2ϩ cycling ability (reduced PS at high stimulating frequencies) in cardiomyocytes from aged animals.
Recent evidence indicates that the small GTPase RhoA participates in the regulation of multiple cell functions, including adhesion, proliferation, migration, and Ca 2ϩ homeostasis through kinase cascade activation. The Rho family consists of several members among which RhoA is the most ubiquitously and abundantly expressed in the body. RhoA cycles between two states, an inactive GDP-bound form and an active GTP-bound form that translocates to the membrane where it acts on various effector molecules. Enhanced RhoA activity has been shown to lead to oxidative stress (45, 46) . Meanwhile, up-regulation of RhoA protein has been reported in aged blood vessels (47) . Likewise, our data show RhoA activity is increased in aged cardiomyocytes, and this effect is reduced by metallothionein over-expression. Our observation that the aging-associated cardiomyocyte dysfunction may be ablated by the Rho kinase inhibitor Y-27632 provided further convincing support to the involvement of RhoA in cardiac aging.
The mechanical and intracellular Ca 2ϩ defects triggered by advanced age were alleviated by metallothio- nein, in a manner similar to its effect on diabetesinduced cardiac contractile dysfunctions (13) . Metallothionein offered protection of cardiomyocyte function in type 1 diabetes and insulin resistance due to its antioxidant action (13, 45) . This is supported by our present finding in that metallothionein antagonizes aging-induced up-regulation of NADPH oxidase subunit p47 phox , superoxide generation, and propensity to pyrogallol-induced superoxide generation and apoptosis, as well as other biomarkers of oxidative stress including increased cytochrome c release and decreased aconitase activity. The lack of effect on protein nitration suggests that reactive nitrogen species may not be playing a major role in aging-induced cardiac oxidative stress and contractile dysfunction or metallothionein-elicited anti-aging effects. It is also worth mentioning that although aging itself does not trigger a drop in the cardiac metallothionein levels, metallothionein overexpression should help to compensate for the reduced overall antioxidant capacity in aging. We cannot offer any explanation for the age-related increase metallothionein levels in the transgenic mice. It is possible that certain protein-to-protein interaction exists between cardiac senescent proteins and the MHC promoter driving the metallothionein gene. Further study is warranted to elucidate the precise mechanism(s) of aging-related change in antioxidant levels, enhanced oxidative stress, and stress signaling activation in cardiac aging and longevity.
In summary, our data demonstrated that overexpression of metallothionein in the heart could alleviate advanced aging-triggered cardiac contractile defects, while increasing survival, an effect possibly associated with inhibition of NADPH oxidase-mediated superoxide generation, RhoA activation, and enhanced oxidative stress. 
